Tonix Pharmaceuticals Announces Second Major Managed Medicare Agreement For TONMYA

Tonix Pharmaceuticals has announced a second major managed Medicare agreement for its fibromyalgia treatment, TONMYA, which is effective immediately and adds approximately 21 million Medicare lives, bringing total Medicare coverage to 32 million lives in the U.S. This agreement expands total commercial and government payer coverage for TONMYA to about 166 million lives. The company has activated 50 new sales representatives, increasing its sales force to 150, to enhance access and awareness for TONMYA among fibromyalgia patients.